169331 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Human monoclonal antibodies specific for glypican-3 and use thereof
#3902Diagnosis and treatments relating to TH2 inhibition
#3903Diagnosis and treatments relating to TH2 inhibition
#3904Pancreatic cancer biomarker using the characteristics of pancreatic cancer stem cells, and use thereof
#3905Therapeutic and diagnostic methods involving biglycan and utrophin
#3906Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers
#3907BIOMARKERS FOR OVARIAN CANCER
#3908System and method for determining individualized medical intervention for a disease state
#3909Method, array and use for determining the presence of pancreatic cancer
#3910USE OF MARKERS IN THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
#3911NOVEL BIOMARKERS FOR DETECTING NEURONAL LOSS
#3912Thyroglobulin quantitation by mass spectrometry
#3913BREAST CANCER DIAGNOSIS USING NIPPLE DISCHARGE
#3914METHODS FOR DETECTING OR PREDICTING KIDNEY DISEASE
#3915Quantification of single target molecules in histological samples
#3916SNX9 AS A NOVEL BIOMARKER FOR CHRONIC INFLAMMATION AND ASSOCIATED IMMUNOSUPPRESION AND A NEW REGULATOR OF T CELL RECEPTOR EXPRESSION AND FUNCTION
#3917Molecular subtyping, prognosis and treatment of prostate cancer
#3918DIAGONSIS AND TREATMENT OF AUTOIMMUNE DISEASES BY TARGETING AUTOIMMUNE-RELATED B CELLS ("ABCS")
#3919BIOMARKERS AND METHODS OF TREATMENT
#3920Antibody molecules
#3921GPNMB/OSTEOACTIVIN AS A BIOMARKER AND DRUG TARGET IN CARDIAC DISEASES
#3922Method of detecting pancreatic disease and pancreas testing kit
#3923Means and Methods for Diagnosing Gastric Bypass and Conditions Related Thereto
#3924Antibody reacting with native Cochlin-tomoprotein (CTP) and method for measuring CTP using same
#3925SOLUBLE HUMAN M-CSF RECEPTOR AND USES THEREOF
#3926BIOMARKERS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#3927Biomarkers for Diseases of the Central Nervous System
#3928NLRP7-BASED DIAGNOSIS OF FEMALE REPRODUCTIVE CONDITIONS
#3929Novel tumor marker, its monoclonal antibodies and usage
#3930Methods for Diagnosing and Treating Iron Dysregulation
#3931Methods of administering D-dopachrome tautomerase (D-DT) to treat ischemia-reperfusion injury
#3932METHODS OF DIAGNOSING AND TREATING AGE-RELATED MACULAR DEGENERATION
#3933Methods of diagnosing endometriosis
#3934Non-uniform channel junction-less transistor
#3935Surrogates of post-translationally modified proteins and uses thereof
#3936Methods and compositions for biomarkers of fatigue
#3937PROTEIN
#3938Exosomal Biomarkers for Cardiovasular Events
#3939Methods for selecting medications for treating patients having attention-deficit hyperactivity disorder
#3940SOLUBLE ICAM-1 AS BIOMARKER FOR PREDICTION OF THERAPEUTIC RESPONSE
#3941PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF TH3 MARCH-RELATED DISEASES
#3942METHODS OF DIAGNOSING AND TREATING INTESTINAL GRANULOMAS AND LOW BONE DENSITY IN INFLAMMATORY BOWEL DISEASE
#3943Method for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells
#3944BIOLOGICAL MARKERS PREDICTIVE OF ANTI-CANCER RESPONSE TO EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITORS
#3945Method for screening for a cancer treatment agent using the interaction between PAUF and a binding partner thereof
#3946METHOD AND DEVICE TO DETECT, MONITOR AND PROMOTE NEURAL REGENERATION AND IMPROVEMENT OF COGNITIVE FUNCTION IN A SUBJECT SUFFERING FROM NEURAL INJURY
#3947THERANOSTIC AND DIAGNOSTIC METHODS USING SPARC AND HSP90
#3948COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
#3949MEASUREMENT OF C-TERMINAL proSP-B
#3950Prognosis and risk assessment in stroke patients by determining the level of marker peptides
#3951Method for determining the risk of cardiovascular events using IGFBP fragments
#3952METHODS OF DIAGNOSING ULCERATIVE COLITIS AND CROHN'S DISEASE
#3953PROCESS AND KIT FOR IN VITRO DIAGNOSIS OF A PROSTATE CANCER
#3954Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood
#3955Biomarkers for acute kidney injury
#3956PATHWAY CHARACTERIZATION OF CELLS
#3957Biomarkers for systemic lupus erythematosus
#3958SERUM MARKERS FOR IDENTIFICATION OF CUTANEOUS SYSTEMIC SCLEROSIS SUBJECTS
#3959Modulating Endoplasmic Reticulum Stress in the Treatment of Tuberous Sclerosis
#3960Methods Of Predicting Response To JNK Inhibitor Therapy
#3961Methods for treating metabolic syndrome with Cthrc1 polypeptide
#3962BAP1 MUTATIONAL ANALYSIS IN DETERMINING SUSCEPTIBILITY TO, PROGNOSIS OF, AND TREATMENT OF MELANOCYTIC NEOPLASIA
#3963Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
#3964METHOD OF DIAGNOSING THE PRESENCE AND/OR SEVERITY OF A HEPATIC PATHOLOGY IN AN INDIVIDUAL AND/OR OF MONITORING THE EFFECTIVENESS OF A TREATMENT FOR ONE SUCH PATHOLOGY
#3965Leukocyte activation and methods of use thereof
#3966Novel Antibodies and Uses Thereof
#3967Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles
#3968FEN1 AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
#3969ASC as a marker for chronic obstructive pulmonary disease (COPD)
#3970Antibody for detecting DNA damage in cells utilizing cell membrane surface antigen Ly6D
#3971MARKER FOR DIAGNOSING DIABETIC RETINOPATHY AND USE THEREOF
#3972USE OF SOMATIC MUTATIONS IN THE EXTRACELLULAR DOMAIN OF TRANSMEMBRANE PROTEINS IN A PATIENT'S TUMOR AS IMMUNOGENS FOR ACTIVE HUMORAL IMMUNOTHERAPY OF CANCER
#3973ANTI-MESOTHELIN BINDING PROTEINS
#3974METHODS FOR TREATING OR PREDICTING RISK OF A VENTRICULAR TACHYARRHYTHMIA EVENT
#3975Combination for early exclusion of acute myocardial infarction
#3976Use of stathmin as a biomarker of drug response to furazanobenzimidazoles
#3977Methods for improving diabetes management
#3978Pharmaceutical composition comprising CCN5 for reducing cardiac fibrosis in a subject in need thereof
#3979USE OF ALPHA-2-MACROGLOBULIN FOR DETERMINING OSTEONECROSIS DISEASE STATUS AND FOR SCREENING THERAPEUTIC AGENTS FOR PREVENTING OR TREATING OSTEONECROSIS
#3980ARMET AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
#3981Diagnosis of acute coronary syndrome, myocardial infarction, or angina pectoris by means of neurophysin II
#3982USE OF HEMATOPOIETIC GROWTH FACTOR INDUCIBLE NEUROKININ-1 (HGFIN) AS A NOVEL BIOMARKER
#3983IDENTIFICATION OF CANCER PATIENTS LIKELY TO BENEFIT FROM RADIATION THERAPY
#3984SEPRASE AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
#3985APEX1 AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
#3986NNMT AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
#3987Methods for determining the risk of prenatal complications
#3988USE OF NOVEL CYTOKINE RECEPTORS AS BIOMARKERS AND THERAPEUTIC TARGETS IN HUMAN CANCER
#3989MYH10 AS A NEW MARKER OF PATHOLOGIES RESULTING FROM RUNX1 INACTIVATION
#3990METHOD OF DIAGNOSING BREAST CARCINOMA
#3991MOLECULAR DIAGNOSIS AND CLASSIFICATION OF MALIGNANT MELANOMA
#3992Compositions and methods for diagnosing and treating kidney disorders in a feline
#3993DETECTION OF AN IMMUNE RESPONSE
#3994MODULATION OF HISTONE H2B MONOUBIQUITINATION AND TREATMENT OF CANCER
#3995Compositions and methods for diagnosing and treating phenylketonuria (PKU)
#3996Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
#3997Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
#3998Method of predicting acute appendicitis
#3999Human βV-tubulin antibody and methods of use
#4000Metabolic diseases-related odorant receptor genes and use thereof
#4001Diagnostic and Prognostic Markers for Metastasis
#4002TAZ/WWTR1 for diagnosis and treatment of cancer
#4003Predictive Markers For Cancer and Metabolic Syndrome
#4004Prognostic Marker for Endometrial Carcinoma
#4005URINARY sCD14 AS A BIOMARKER FOR CORONARY ARTERY DISEASE
#4006METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN sVCAM AND/OR sMadCAM LEVELS
#4007Use of ide as a biomarker for a scalp condition
#4008Engineered type IV pilin of
#4009Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
#4010Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
#4011Tumor specific antibodies and uses therefor
#4012Anti-LGR5 antibodies and immunoconjugates
#4013AUTO-ANTIGEN BIOMARKERS FOR LUPUS
#4014METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#4015Methods, kits and systems for signal amplification for bioassays using zinc nanoparticles
#4016Composition and method for the diagnosis and treatment of iron-related disorders
#4017Levels of BLyS/APRIL heterotrimers in serum and use in diagnostic methods
#4018Means and methods for the prediction of treatment response of a cancer patient
#4019Tau imaging probe
#4020Treating renal and liver dysfunction with TLR4 antagonists
#4021Animal model for diabetic complications
#4022Composition of diagnostic biomarker for stomach cancer and method of diagnosing stomach cancer using the composition
#4023Spinal muscular atrophy diagnostic methods
#4024Urine biomarkers for prediction of recovery after acute kidney injury: proteomics
#4025Methods for the identification and treatment of patients sensitive to anti IGF-1R inhibition therapy
#4026Inhibition of delta-6 desaturase for the treatment of cardiometabolic disease
#4027Methods for treatment of cardiovascular disease
#4028METHOD FOR THE MONITORING OF SMOKING CESSATION COMPLIANCE AND RECOVERY, THERAPEUTIC INTERVENTION, AND RISK MANAGEMENT
#4029METHODS FOR DIAGNOSIS OF KAWASAKI DISEASE
#4030BIOMARKERS FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS
#4031Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95
#4032BNP-SP antibodies
#4033BREAST CANCER DIAGNOSTICS
#4034Method of Differentiating Oncogenic Changes of the Thyroid, A Kit to Embody the Method and the Use of Metallothionein (MT) for Differentiating Oncogenic Changes of the Thyroid
#4035Test kit for plasma or serum antibody titer against periodontal disease-causing bacteria
#4036METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#4037Method for the diagnosis of a carcinoma and uses thereof
#4038METHOD FOR DETERMINING CANCER PROGNOSIS
#4039Cross Protective Epitopes of Aspergillus Fumigatus and Candida Albicans
#4040METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS
#4041Method and kits for determining platelet susceptibility to activation in a patient
#4042DIAGNOSTIC AGENT FOR ISCHEMIC HEART DISEASE RISK GROUP
#4043Method for assessing a subject's risk of having a cardiovascular disease
#4044Methods and means for diagnosing vasculitis
#4045Tuberculosis diagnostic test
#4046Quantitative methods and kits for providing reproducible IHC4 scores
#4047METHODS OF DIAGNOSING ASTHMA
#4048MARKERS FOR DETECTING HUMAN FOLLICULAR HELPER T CELLS AND METHOD FOR DETECTING HUMAN FOLLICULAR HELPER T CELLS
#4049TETRAMERIC ALPHA-SYNUCLEIN AS BIOMARKERS
#4050BIOMARKERS, USES OF BIOMARKERS AND A METHOD OF IDENTIFYING BIOMARKERS
#4051JAGGED1 AS A MARKER AND THERAPEUTIC TARGET FOR BREAST CANCER BONE METASTASIS
#4052PROGNOSTIC SIGNATURE FOR ORAL SQUAMOUS CELL CARCINOMA
#4053Methods for treating chronic pelvic pain syndrome
#4054PROGNOSIS AND RISK ASSESSMENT OF PATIENTS WITH NON-SPECIFIC COMPLAINTS
#4055Method for predicting the response to HER2-directed therapy
#4056Method For Evaluating Atherosclerotic Lesion, And Kit
#4057METHOD FOR THE EARLY IDENTIFICATION AND PREDICTION OF AN ABRUPT REDUCTION IN KIDNEY FUNCTION IN A PATIENT UNDERGOING CARDIOTHORACIC SURGERY
#4058Methods for diagnosing episodic movement disorders and related conditions
#4059BCL-2-like protein 11 SRM/MRM assay
#4060Biomarkers for pneumonia and acute decompensated heart failure
#4061Targeting metabolic enzymes in human cancer
#4062translocated substrate-1 (Ats-1) and sero-detection of
#4063METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF CROHN'S DISEASE
#4064FOXA1 AS A MARKER FOR INVASIVE BLADDER CANCER
#4065HISTONE PROTEIN UBIQUITINATION AS A CANCER BIOMARKER
#4066Method to increase specificity and/or accuracy of lateral flow immunoassays
#4067Methods and Compositions for the Treatment and Diagnosis of Breast Cancer
#4068MARKER OF BREAST TUMORS FROM THE LUMINAL-B SUBTYPE
#4069COMPOSITIONS AND METHODS RELATING TO MOUSE PAPILLOMA VIRUS
#4070Her3 protein SRM/MRM assay
#4071Anti-HLA monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulin
#4072Highly sensitive system and method for analysis of troponin
#4073Specific A1AT monoclonal antibodies for detection of endometriosis
#4074Method for prediction of prognosis of sepsis
#4075Recombinant deamidated gliadin antigen
#4076Lung cancer differential marker
#4077Biomarkers for prediction of major adverse cardiac events and uses thereof
#4078Selective Reaction Monitoring (SRM) Derived Protein Profiles for Cancer and other Pathologic Entities
#4079BIOMARKERS, USES OF BIOMARKERS AND A METHOD OF IDENTIFYING BIOMARKERS
#4080MODULATION OF HISTONE H2B MONOUBIQUITINATION AND TREATMENT OF CANCER
#4081Biomarkers for theranostics
#4082DDX3 as a biomarker for cancer and methods related thereto
#4083SPARC MICROENVIRONMENT SIGNATURE, PLASMA SPARC, AND LDH AS PROGNOSTIC BIOMARKERS IN THE TREATMENT OF CANCER
#4084Novel biomarker for non-alcoholic fatty liver disease, and method for detecting non-alcoholic fatty liver disease by using the biomarker
#4085Biomarkers for the Diagnosis of ALS
#4086Oxidative stress responsive apoptosis inducing protein eIF5A
#4087Total and phosphorylated IL-1 receptor-associated kinase-1 and IL-1 receptor-associated kinase-4 as a biomarker for cancer progression and chemotherapy resistance
#4088Methods for reducing the risk of spontaneous abortion in a human female comprising administering an effective amount of G-CSF
#4089Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume
#4090Screening methods for identifying Sp35 antagonists
#4091Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#4092Upregulation of rack-1 in melanoma and its use as a marker
#4093Diagnostic assays and methods of use for detection of filarial infection
#4094Tyrosine-phosphorylated WBP2, a novel cancer target and biomarker
#4095PREDICTIVE MARKERS AND BIOMARKER PANELS FOR OVARIAN CANCER
#4096Biomarkers associated with nephropathy
#4097Body fluid BIN1 as a marker of cardiac health
#4098In vitro method for diagnosing or predicting hypertension and/or early-stage cardiovascular end-organ damage by determining the concentration of soluble prorenin receptor
#4099METHOD OF DETECTING PROTEIN LOSING ENTEROPATHY IN ANIMALS
#4100PLASMA BIOMARKER FOR DISTAL METASTASIS IN COLORECTAL CANCER
#4101METHOD OF DETERMINING RISK OF SCOLIOSIS
#4102Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing PDGFR-ALPHA
#4103Means and methods for diagnosing cancer using an antibody which specifically binds to BRAF V600E
#4104Microvesicle protein for cancer targeting
#4105Methods and Compositions for Using Insulin-Like Growth Factor Binding Protein 6 in Treating and Diagnosing Diabetes
#4106Compositions and methods for treatment of drug resistant multiple myeloma
#4107METHODS FOR DETECTING INFLAMMATORY BOWEL DISEASE
#4108DIAGNOSTIC METHODS FOR INFLAMMATORY DISORDERS
#4109POLYPEPTIDE MARKERS FOR THE DIAGNOSIS OF CANCERS, AND METHODS FOR THE DIAGNOSIS OF CANCERS USING THE SAME
#4110Highly sensitive biomarker panels
#4111DIAGNOSTIC METHODS USING BNP
#4112Biomarkers for determining breast cancer bone metastasis
#4113METHOD FOR THE DIAGNOSIS AND/OR PROGNOSIS OF INFLAMMATORY STATES
#4114TEM-1 diagnostic antibodies
#4115Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof
#4116CLASS I MHC PHOSPHOPEPTIDES FOR CANCER IMMUNOTHERAPY AND DIAGNOSIS
#4117Reagents, methods, and kits for the classification of cancer
#4118Compositions and methods for diagnosing and treating an inflammation
#4119DIAGNOSIS AND TREATMENTS RELATING TO HER3 INHIBITORS
#4120CLIP INHIBITORS AND METHODS OF MODULATING IMMUNE FUNCTION
#4121CAMKK-BETA AS A TARGET FOR TREATING CANCER
#4122ACTIVATING PHOSPHORYLATION SITE ON GLUTAMINASE C
#4123Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#4124Use of IMP3 as a prognostic marker for cancer
#4125METHOD FOR MEASURING RESISTANCE OR SENSITIVITY TO DOCETAXEL
#4126Diagnostic test for cardiomyopathy
#4127DRG11-RESPONSIVE (DRAGON) GENE AND USES THEREOF
#4128DIAGNOSTIC METHOD
#4129Method of detecting a urine protein fragment and a serum protein fragment
#4130Method for the diagnosis and/or prognosis of granulocyte-related inflammatory states
#4131SCLEROSTIN AND THE INHIBITION OF WNT SIGNALING AND BONE FORMATION
#4132Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies
#41331L1RL-1 as a cardiovascular disease marker and therapeutic target
#4134Method For Selecting Or Identifying A Subject For V1B Antagonist Therapy
#4135ASSAYS AND METHODS FOR DETERMINING RISK OF A MACROPHAGE-MEDIATED DISEASE DEVELOPMENT IN A SUBJECT INFECTED WITH HIV
#4136Detecting infection in reduced pressure wound treatment
#4137Method of identifying when a patient undergoing hemodialysis is at increased risk of death
#4138Sensitive and specific assay for spp
#4139Compositions and Methods for Treating and Diagnosing Cancer
#4140Predicting risk of major adverse cardiac events
#4141Cancer-associated antigen
#4142METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY
#4143Method for cancer detection
#4144TREATMENT
#4145Systems and methods using biomarker panel data
#4146Detection of nucleic acids and proteins
#4147Methods and compositions for biomarkers of fatigue, fitness and physical performance capacity
#4148Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#4149ALBUMIN-BOUND PROTEIN/PEPTIDE COMPLEX AS A BIOMARKER FOR DISEASE
#4150D-DIMER, TROPONIN, AND NT-PROBNP FOR PULMONARY EMBOLISM
#4151Method for predicting a need for renal replacement therapy (RRT)
#4152Red blood cell dynamics for administering treatment for iron-deficiency anemia
#4153LEISHMANIASIS ANTIGEN DETECTION ASSAYS AND VACCINES
#4154Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#4155Compositions, methods and kits for diagnosis of lung cancer
#4156METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#4157USE OF URINARY NGAL TO DIAGNOSE UNILATERAL AND BILATERAL URINARY OBSTRUCTION
#4158Monocyte-derived Nucleic Acids and Related Compositions and Methods
#4159Protein kinase ck2 gene mutations, amplifications and polymorphisms in human cancers and methods of use
#4160Myomegalin variant 8
#4161Feline morbillivirus and uses thereof
#4162Analyzing semaphorin7a (Sema7A) levels for assessing cancer metastatic potential and methods of treatment
#4163Methods for improving inflammatory bowel disease diagnosis
#4164PROSTATE CANCER MARKERS AND USES THEREOF
#4165METHODS AND COMPOSITIONS FOR TREATMENT OF TOX-3 AND TFF-1 MEDIATED CANCER PATHOGENESIS
#4166LIVER DISEASE MARKERS
#4167METHODS AND COMPOSITIONS FOR DETECTING ENDOMETRIAL OR OVARIAN CANCER
#4168ESTROGEN RECEPTOR ALPHA POLYPEPTIDE SEQUENCE, DIAGNOSTIC AND THERAPEUTIC APPLICATIONS THEREOF
#4169METHODS FOR DIAGNOSING AND TREATING PROSTATE AND LUNG CANCER
#4170Methods and drugs targeting Eva1 or Ceacam1 gene expression for treatment and diagnosing of glioma
#4171NOTUM PROTEIN MODULATORS AND METHODS OF USE
#4172Inhibition of tat activating regulatory DNA-binding protein 43
#4173METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING LUPUS
#4174Marker Sequences for Inflammatory Prostate Diseases, Prostate Carconoma and Their Use
#4175METHODS FOR DETERMINING A PROGNOSIS FOR SURVIVAL FOR A PATIENT WITH LEUKAEMIA
#4176Kits for detecting breast or ovarian cancer in a body fluid sample and use thereof
#4177FACTOR INVOLVED IN LATENT INFECTION WITH HERPESVIRUS, AND USE THEREOF
#4178C-CBL MUTATIONS AND USES THEREOF
#4179DIAGNOSTIC BIOMARKERS OF DIABETES
#4180Avian group D rotavirus
#4181Stromal Antigen 2 (STAG2) Compositions and Methods
#4182REAGENT FOR TUMOR TESTING AND PHARMACEUTICAL COMPOSITION FOR TUMOR PREVENTION
#4183Stat5b transgenic mice and methods of use thereof
#4184METHOD OF IDENTIFYING TRIPLE NEGATIVE BREAST CANCER
#4185Compositions and methods to control angiogenesis with cupredoxins
#4186Moesin fragments and uses thereof
#4187REAGENTS AND METHODS FOR USE IN CANCER DIAGNOSIS, CLASSIFICATION AND THERAPY
#4188Biomarkers for Predicting Kidney and Glomerular Pathologies
#4189METHODS AND COMPOUNDS FOR THE DIAGNOSIS AND TREATMENT OF CANCER
#4190MARKERS OF VULNERABILITY OF THE ATHEROSCLEROSIS PLAQUE
#4191diagnostics and screening methods
#4192RATIO BASED BIOMARKERS AND METHODS OF USE THEREOF
#4193METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#4194DIAGNOSTIC AND PROGNOSTIC METHOD FOR HUMAN TAUOPATHIES
#4195Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#4196BLOOD INSULIN RESISTANCE AND DIABETES MARKER PROGRANULIN, METHOD FOR ANALYZING CONCENTRATION OF PROGRANULIN IN BLOOD SAMPLE, AND METHOD FOR SCREENING FOR SUBSTANCE THAT IMPROVES INSULIN RESISTANCE AND IMPROVES OR SUPPRESSES DIABETES
#4197Method for diagnosing Q-fever using a cellular immunological test
#4198COMPLEX PHOSPHOPROTEIN ACTIVATION PROFILES
#4199METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE IN A NON-SURGICAL ICU POPULATION
#4200BIOLOGICAL MARKERS PREDICTIVE OF ANTI-CANCER RESPONSE TO KINASE INHIBITORS